Clinical Trial Update: Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress [Phase 2]

View source ↗

Summary

Phase 2 study investigating allogeneic adipose-derived mesenchymal stem cells for treating COVID-19 acute respiratory distress; status unclear from provided sni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Allogeneic adipose-derived mesenchymal stem cells (allogeneic adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Sorrento Therapeutics, Inc. | Conditions: Covid19 | Phase 2 | Status: UNKNOWN